Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

73.78 +2.19 (+3.06%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research
From Tempus AI, Inc.
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
From Pomerantz LLP
Via GlobeNewswire
Cathie Wood Sharers Her Take On Chatbots And Robots Taking Human Jobs: 'We'll See More People Taking Risks'
Cathie Wood argues that AI will create more jobs than it displaces, and predicts a radical change in traditional corporations. Her thesis aligns with ARK Invest's investments in chipmakers and software... 
Via Benzinga
Topics Artificial Intelligence
Why Shares of Tempus AI Are Jumping Higher This Week
Via The Motley Fool
Topics Artificial Intelligence
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
From Pomerantz LLP
Via GlobeNewswire
Update! What Is Congress Trading So Far In 2025?
Members of Congress are trading less than usual in 2025 but haven't completely given it up; this is a look at who traded what in the first half. 
Via MarketBeat
TEMPUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Tempus AI, Inc. on Behalf of Tempus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Tempus AI Stock Soared 15% Today
Via The Motley Fool
Topics Artificial Intelligence Stocks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
From Pomerantz LLP
Via GlobeNewswire
TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
Tempus AI Stock Rockets After Introduction Of Liquid Biopsy Assay For Cancer Treatment Monitoring: Retail Hopes For A 20% Rally
The company stated that the assay, currently available for research use, will be clinically available later this year. 
Via Stocktwits
Topics Artificial Intelligence
Tempus AI Stock Is Surging Today: What Investors Are Watching
Tempus AI Inc (NASDAQ:TEM) shares are moving higher Monday after the company introduced a new program to monitor immunotherapy response for patients with advanced cancer. 
Via Benzinga
Topics Artificial Intelligence
Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers
From Tempus AI, Inc.
Via Business Wire
Introducing Tempus One in the EHR with Integrated Guidelines
From Tempus AI, Inc.
Via Business Wire
Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model
From Tempus AI, Inc.
Via Business Wire
Tempus AI Stock: Buy the Dip, or Is the Short-Seller Right?
Via The Motley Fool
Topics Artificial Intelligence
Why Tempus AI Stock Plummeted This Week
Via The Motley Fool
Topics Artificial Intelligence
Real-World Deployments Signal AI Healthcare Is Ready for Scale
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:BTAI),(OTCPK:HWAIF),(OTCQX:WHTCF) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting
From Tempus AI, Inc.
Via Business Wire
Tempus: Short Seller Attack Brings Golden Opportunity Cathie Wood Was Waiting For
ARK ETFs' Cathie Wood buys 251,080 shares of Tempus AI, a precision medicine company, amid short seller attack and bullish technical indicators.>ARK ETFs' Cathie Wood buys 251,080 shares of Tempus AI,... 
Via Benzinga
Topics Artificial Intelligence
Nvidia, Apple, Amazon, Tempus AI, Tesla: Why These 5 Stocks Are On Investors' Radars Today
The Dow Jones Industrial Average falling 0.6% to 42,098.70 and the S&P 500 slipping by a similar margin to 5,888.55 on Wednesday. 
Via Benzinga
Topics Artificial Intelligence Stocks
Tempus AI, Inc. (NASDAQ: TEM) Securities Fraud Investigation; Investors Urged to Contact Award-Winning Firm, Gibbs Mura
From Gibbs Mura
Via Business Wire
Cathie Wood Ditches $5.6M More Tesla While Elon Musk Quits Government Role — Doubles Down On AI Stock Under Attack By Short Sellers
ARK Invest, led by Cathie Wood, made significant trades involving Tesla and Tempus AI amid insider sales and short seller scrutiny. $5.6 million in Tesla shares sold, $13.36 million in Tempus AI shares... 
Via Benzinga
Topics Artificial Intelligence
TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Rosen Law Firm Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation – TEM
From The Rosen Law Firm, P.A.
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Tempus AI, Inc. – TEM
From Pomerantz LLP
Via GlobeNewswire
A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today
Via The Motley Fool
Topics Artificial Intelligence Stocks
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.